These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1018 related items for PubMed ID: 16996615

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
    Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, Feldman BM, Laxer RM, Schneider R, Silverman ED.
    Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D.
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [Abstract] [Full Text] [Related]

  • 4. [The treatment of recurrent uveitis with TNF-alpha inhibitors].
    Falappone PC, Iannone F, Scioscia C, Grattagliano V, Covelli M, Lapadula G.
    Reumatismo; 2004 Feb; 56(3):185-9. PubMed ID: 15470524
    [Abstract] [Full Text] [Related]

  • 5. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
    Kakkassery V, Mergler S, Pleyer U.
    Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS.
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Retrospective case review of pediatric patients with uveitis treated with infliximab.
    Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS.
    Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.
    Tynjälä P, Lindahl P, Honkanen V, Lahdenne P, Kotaniemi K.
    Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061
    [Abstract] [Full Text] [Related]

  • 18. Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital.
    Petropoulos IK, Vaudaux JD, Guex-Crosier Y.
    Klin Monbl Augenheilkd; 2008 May; 225(5):457-61. PubMed ID: 18454398
    [Abstract] [Full Text] [Related]

  • 19. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
    Gerloni V, Pontikaki I, Gattinara M, Fantini F.
    Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
    [Abstract] [Full Text] [Related]

  • 20. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
    Jonsdottir T, Forslid J, van Vollenhoven A, Harju A, Brannemark S, Klareskog L, van Vollenhoven RF.
    Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.